> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Releases Product-Specific BE Guidance
- URL: https://www.fdaweb.com/fda-releases-product-specific-be-guidance/
- Published: 2016-01-28T12:00:00.000Z
- Updated: 2026-09-15T02:31:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134600

*Federal Register* Notice: FDA is making available additional draft and revised draft product-specific bioequivalence (BE) recommendations for 31 products. The recommendations provide product-specific guidance on the design of BE studies to support ANDAs. The products include recommendations for alprostadil, betamethasone dipropionate, ciclesonide, and elvitegravir. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-01-28/pdf/2016-01682.pdf?ref=fdaweb.com)